RIZARG Trademark

Trademark Overview

On Tuesday, March 12, 2013, a trademark application was filed for RIZARG with the United States Patent and Trademark Office. The USPTO has given the RIZARG trademark a serial number of 79129611. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, April 6, 2016. This trademark is owned by Novartis AG. The RIZARG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in ophthalmology, in transplantation; pharmaceutical preparations for use in the gastroenterological area, for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of bacteria-based diseases, anti-infectives, antivirals, antibiotics, antifungals; vaccines, and diagnostic preparations for medical use
rizarg

General Information

Serial Number79129611
Word MarkRIZARG
Filing DateTuesday, March 12, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, April 6, 2016
Registration Number4737050
Registration DateTuesday, May 19, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in ophthalmology, in transplantation; pharmaceutical preparations for use in the gastroenterological area, for the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for the treatment of bacteria-based diseases, anti-infectives, antivirals, antibiotics, antifungals; vaccines, and diagnostic preparations for medical use
Translation of Words in MarkThe word(s) "RIZARG" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, April 6, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, October 27, 2017NOTIFICATION PROCESSED BY IB
Friday, May 12, 2017NOTIFICATION PROCESSED BY IB
Thursday, April 21, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, April 21, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, October 2, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 9, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 9, 2015FINAL DISPOSITION PROCESSED
Wednesday, August 19, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 19, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2015PUBLISHED FOR OPPOSITION
Friday, February 27, 2015NOTIFICATION PROCESSED BY IB
Wednesday, February 11, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 11, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 24, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 5, 2015ASSIGNED TO LIE
Friday, December 26, 2014REFUSAL PROCESSED BY IB
Monday, December 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 2, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 2, 2014REFUSAL PROCESSED BY MPU
Tuesday, December 2, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 1, 2014NON-FINAL ACTION WRITTEN
Tuesday, November 25, 2014ASSIGNED TO EXAMINER
Tuesday, November 25, 2014CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, November 14, 2014CORRECTION TRANSACTION RECEIVED FROM IB
Monday, September 8, 2014TEAS REQUEST FOR REINSTATEMENT
Sunday, August 17, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, August 17, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 28, 2013APPLICATION FILING RECEIPT MAILED
Wednesday, May 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 20, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, May 18, 2013DEATH OF INTERNATIONAL REGISTRATION
Thursday, May 16, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

rizarg system preparations treatment pharmaceutical diseases disorders prevention bacteria ocular based